Shimasaki, M.; Ueda, S.; Sakurai, M.; Kawahara, N.; Ueda, Y.; Ichiseki, T.
Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro. Biomolecules 2024, 14, 1636.
https://doi.org/10.3390/biom14121636
AMA Style
Shimasaki M, Ueda S, Sakurai M, Kawahara N, Ueda Y, Ichiseki T.
Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro. Biomolecules. 2024; 14(12):1636.
https://doi.org/10.3390/biom14121636
Chicago/Turabian Style
Shimasaki, Miyako, Shusuke Ueda, Masaru Sakurai, Norio Kawahara, Yoshimichi Ueda, and Toru Ichiseki.
2024. "Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro" Biomolecules 14, no. 12: 1636.
https://doi.org/10.3390/biom14121636
APA Style
Shimasaki, M., Ueda, S., Sakurai, M., Kawahara, N., Ueda, Y., & Ichiseki, T.
(2024). Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro. Biomolecules, 14(12), 1636.
https://doi.org/10.3390/biom14121636
